Last reviewed · How we verify
NCT04149054
Mobile Health App to Reduce Diabetes in Latina Women
Phase 1 trial testing Mobile health app called "Hola Bebe" in Gestational Diabetes in 18 participants. Completed in 30 April 2017.
30 April 2017
Quick facts
| Lead sponsor | Environment and Health Group, Inc. |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 18 |
| Start date | 22 July 2014 |
| Primary completion | 30 April 2017 |
| Estimated completion | 30 April 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Mobile health app called "Hola Bebe"
Conditions studied
- Gestational Diabetes — all drugs for Gestational Diabetes →
Sponsor
Environment and Health Group, Inc.
Who can join
Adults 19 to 45, female only, with Gestational Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The proposed project sought to develop a culturally- and individually-tailored, plain-language Spanish/English mobile phone intervention for Latinas with prior gestational diabetes (GDM). The intervention is based on earlier in-person to online modification of the CDC-funded Diabetes Prevention Program (DPP), for women with prior GDM led by co-investigator Dr. Ellen Seely of Brigham and Women's Hospital.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Development and Feasibility of an App to Decrease Risk Factors for Type 2 Diabetes in Hispanic Women With Recent Gestational Diabetes (Hola Bebé, Adiós Diabetes): Pilot Pre-Post Study.
Seely EW, Weitzman PF, Cortes D, Romero Vicente S, et al · · 2020 · cited 12× · PMID 33382039 · DOI 10.2196/19677
Verify or expand the search:
- PubMed search for NCT04149054
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gestational Diabetes
Currently open trials in the same condition.
- NCT07171684 — Single vs Multi-Dose Insulin for Glycemic Control (SUGAR) · NA · recruiting
- NCT07314944 — Maternal Sleep and Lifestyle, Metabolic Health, and Perinatal Outcomes in Gestational Diabetes · recruiting
- NCT06571487 — Growth Hormone Resistance of Beta-cells · recruiting
- NCT07336914 — Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes · NA · recruiting
- NCT07174245 — Pregnancy and Postpartum CGM in GDM · recruiting
Other Environment and Health Group, Inc. trials
Trials by the same sponsor.
- NCT05009004 — Digital Health for Medication Adherence Among African Americans With Hypertension · NA · completed
- NCT04633200 — Mhealth for PrEP Adherence by Young Adult MSM, Phase 2 · NA · completed
- NCT05489172 — Mobile Health App to Reduce Diabetes in Latina Women With Prior Gestational Diabetes II · NA · completed
- NCT04557332 — mHealth for ART Adherence by HIV+ African Americans · Phase 2 · completed
- NCT04233931 — Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04149054 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Environment and Health Group, Inc.
- Last refreshed: 4 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04149054.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing